Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading MAGELLAN® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; Influx®, a natural bone-graft material; and CellPoint®, a concentrated bone marrow aspirate system.
View Top Employees from Arteriocyte (Now Isto Biologics)| Website | http://www.istobiologics.com |
| Employees | 21 (16 on RocketReach) |
| Founded | 1997 |
| Phone | +1 866-660-2674 |
| Industry | Medical Devices, Health Care, Platelet Rich Plasma, Medical Device |
| Web Rank | 7 Million |
| Keywords | Isto Biologics, New Orleans Conference February 20, 2019 |
Looking for a particular Arteriocyte (Now Isto Biologics) employee's phone or email?
Arteriocyte (Now Isto Biologics) Questions
Donald Brown is the CEO of Arteriocyte (Now Isto Biologics).
16 people are employed at Arteriocyte (Now Isto Biologics).
Arteriocyte (Now Isto Biologics) is based in Hopkinton, Massachusetts.
Top Arteriocyte (Now Isto Biologics) Employees
-
45+
-
35+
-
View
Amy Goldberg
Eastern Sales Manager, TRU at Arteriocyte (Now Isto Biologics)
Philadelphia, PA, US31 -
Viewj.p Calkins
Associate Sales Representative- Regenerative Medicine and Central Midwest Region at Arteriocyte (Now Isto Biologics)
Chicago, Illinois, United States1 -
Viewj.p Calkins
Regional Sales Associate at Arteriocyte (Now Isto Biologics)
Chicago, Illinois, United States -
Related Companies
